Association between stressful life events and exacerbation in multiple sclerosis: A meta-analysis

British Medical Journal

Volumn 328, Issue 7442, 2004, Pages 731-733

  Mohr, David C ^a   Hart, Stacey L ^a   Julian, Laura ^b   Cox, Darcy ^b   Pelletier, Daniel ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABSTRACT REPORT; BEHAVIOR THERAPY; CONFIDENCE INTERVAL; DISEASE ASSOCIATION; DISEASE EXACERBATION; EMOTIONAL STRESS; HUMAN; IMMUNITY; INJURY; LIFE EVENT; MEDLINE; MENTAL STRESS; META ANALYSIS; MULTIPLE SCLEROSIS; NEUROENDOCRINE SYSTEM; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; PSYCINFO; PUBLICATION; REVIEW; RISK; SAMPLING; TREATMENT PLANNING;

EID: 1642484542     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.38041.724421.55     Document Type: Review

References (16)

1. Hohlfeld R, Meinl E, Weber F, Zipp F, Schmidt S, Sotgiu S, et al. The role of autoimmune T lymphocytes in the pathogenesis of multiple sclerosis. Neurology 1995;45(6 suppl 6):S33-8.
2. Goodin DS, Ebers GC, Johnson KP, Rodriguez M, Stoley WA, Wolinsky JS. The relationship of MS to physical trauma and psychological stress: report of the therapeutics and technology assessment subcommittee of the American Academy of Neurology. Neurology 1999;52:1737-45.
3. Charcot JM. Lectures on diseases of the nervous system. London: New Sydenham Society, 1877.
4. Rabins PV, Brooks BR, O'Donnell P, Pearlson GD, Moberg P, Jubelt B, et al. Structural brain correlates of emotional disorder in multiple sclerosis. Brain 1986;109:585-97.
5. Lipsey MW, Wilson DB. Practical meta-analysis. Thousand Oaks, CA: Sage, 2001.
6. Ackerman KD, Stover A, Heyman R, Anderson BP, Houck PR, Frank E, et al. 2002 Relationship of cardiovascular reactivity, stressful life events, and multiple sclerosis disease activity. Brain Behav Immun 2003;17:141-51.
7. Filippini G, Munari L, Incorvaia B, Ebers GC, Polman C, D'Amico R, et al. Interferons in relapsing remitting multiple sclerosis: a systematic review. Lancet 2003;361:545-52.
8. Mohr DC, Goodkin DE, Bacchetti P, Boudewyn AC, Huang L, Marrietta P, et al. Psychological stress and the subsequent appearance of new brain MRI lesions in MS. Neurology 2000;55:55-61.
9. Nisipeanu P, Korczyn AD. Psychological stress as risk factor for exacerbations in multiple sclerosis. Neurology 1993;43:1311-2.
10. Whitacre CC, Dowdell K, Griffin AC. Neuroendocrine influences on experimental autoimmune encephalomyelitis. Ann N Y Acad Sci 1998;840:705-16.
11. Correa SG, Rodriguez-Galâan MC, Rivero VE, Riera CM. Chronic varied stress modulates experimental autoimmune encephalomyelitis in Wistar rats. Brain Behav Immunity 1998;12:134-48.
12. Mohr DC, Goodkin DE, Islar J, Hauser SL, Genain CP. Treatment of depression is associated with suppression of nonspecific and antigen-specific T(H)1 responses in multiple sclerosis. Arch Neurol 2001;58:1081-6.
13. Munck A, Naray-Fejes-Toth A. Glucocorticoids and stress: permissive and suppressive actions. Ann N Y Acad Sci 1994;746:115-30,131-3.
14. Kino T, Chrousos GP. Glucocorticoid and mineralocorticoid resistance/hypersensitivity syndromes. J Endocrinol 2001;169:437-45.
15. Zappulla JP, Arock M, Mars LT, Liblau RS. Mast cells: new targets for multiple sclerosis therapy? J Neuroimmunol 2002;131:5-20.
16. Goodkin DE, Rooney WD, Sloan R, Bacchetti P, Gee L, Vermathen M, et al. A serial study of new MS lesions and the white matter from which they arise. Neurology 1998;51:1689-97.